跳至主要内容
临床试验/NCT00169013
NCT00169013已完成4 期

Gabapentin in the Prevention of Phantom Limb Pain

Danish Pain Research Center2 个研究点 分布在 1 个国家开始时间: 2002年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
试验地点
2
主要终点
Primary outcome measures:

研究概览

简要总结

To investigate whether gabapentin can prevent phantom and stump pain after amputation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Amputation of crus or femur

排除标准

  • Patients who cannot cooperate
  • Fertile women without sufficient contraceptives
  • Allergy to gabapentin
  • Earlier amputation of the same limb except toes
  • Serious lever, kidney, cardiac, respiratory, haematological disease.-

结局指标

主要结局

Primary outcome measures:

Number of patients with phantom and stump pain 30 days and 6 months after amputation

Average intensity of stump and phantom pain 30 days and 6 months after amputation

次要结局

  • McGill Pain Questionnaire day 7, 14 and 30, and 3 and 6 months
  • Secondary outcome measures:
  • Prevalence and severity of phantom and stump pain at controls day 7, 14 and 30, and 3 and 6 months
  • Concurrent pain medication at day 7, 14 and 30, and 3 and 6 months
  • Brush evoked allodynia, wind up like pain to repetitive pinprick, pressure pain threshold at day 14 and 30.

研究者

发起方
Danish Pain Research Center
申办方类型
Other

研究点 (2)

Loading locations...

相似试验